These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30988606)

  • 1. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits".
    Yii ACA; Loh CH; Tiew PY; Xu H; Taha AAM; Koh J; Tan J; Lapperre TS; Anzueto A; Tee AKH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():719-728. PubMed ID: 30988606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.
    Cardoso J; Coelho R; Rocha C; Coelho C; Semedo L; Bugalho Almeida A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1105-1113. PubMed ID: 29670346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease.
    Bertens LC; Reitsma JB; Moons KG; van Mourik Y; Lammers JW; Broekhuizen BD; Hoes AW; Rutten FH
    Int J Chron Obstruct Pulmon Dis; 2013; 8():493-9. PubMed ID: 24143086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing and validating prediction models for severe exacerbations and readmissions in patients hospitalised for COPD exacerbation (SERCO) in China: a prospective observational study.
    Wang Y; He R; Ren X; Huang K; Lei J; Niu H; Li W; Dong F; Li B; Yang T; Wang C
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38719500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources.
    Hoogendoorn M; Feenstra TL; Boland M; Briggs AH; Borg S; Jansson SA; Risebrough NA; Slejko JF; Rutten-van Mölken MP
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3183-3194. PubMed ID: 29138546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry.
    Kobayashi S; Hanagama M; Ishida M; Sato H; Ono M; Yamanda S; Yamada M; Aizawa H; Yanai M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3947-3955. PubMed ID: 30584294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.
    Chaudhary MFA; Hoffman EA; Guo J; Comellas AP; Newell JD; Nagpal P; Fortis S; Christensen GE; Gerard SE; Pan Y; Wang D; Abtin F; Barjaktarevic IZ; Barr RG; Bhatt SP; Bodduluri S; Cooper CB; Gravens-Mueller L; Han MK; Kazerooni EA; Martinez FJ; Menchaca MG; Ortega VE; Iii RP; Schroeder JD; Woodruff PG; Reinhardt JM
    Lancet Digit Health; 2023 Feb; 5(2):e83-e92. PubMed ID: 36707189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study.
    Adibi A; Sin DD; Safari A; Johnson KM; Aaron SD; FitzGerald JM; Sadatsafavi M
    Lancet Respir Med; 2020 Oct; 8(10):1013-1021. PubMed ID: 32178776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care.
    Duenk RG; Verhagen C; Bronkhorst EM; Djamin RS; Bosman GJ; Lammers E; Dekhuijzen P; Vissers K; Engels Y; Heijdra Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2121-2128. PubMed ID: 28790815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD.
    Kang HS; Rhee CK; Kim SK; Kim JW; Lee SH; Yoon HK; Ahn JH; Kim YH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2467-2473. PubMed ID: 27757029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining prognosis in acute exacerbation of COPD.
    Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty and Exacerbation of Chronic Obstructive Pulmonary Disease: Is There Any Association?
    Nishimura K; Kusunose M; Sanda R; Shibayama A; Nakayasu K
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1131-1139. PubMed ID: 38807967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.
    Aydemir Y; Aydemir Ö; Kalem F
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1045-51. PubMed ID: 25298733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of tidal EFL with exercise performance, exacerbations, and death in COPD.
    Aarli BB; Calverley PM; Jensen RL; Dellacà R; Eagan TM; Bakke PS; Hardie JA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2179-2188. PubMed ID: 28794622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.